Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Recursion Pharmaceuticals A | RXRX | May 16, 2024 | 9.51 | -5.00 |
Red Cat | RCAT | May 16, 2024 | 1.11 | 0.00 |
Red River Bancshares | RRBI | May 16, 2024 | 47.98 | -0.02 |
Red Robin Gourmet Burgers | RRGB | May 16, 2024 | 7.08 | -2.21 |
Red Rock Resorts A | RRR | May 16, 2024 | 51.49 | -1.04 |
Red Violet | RDVT | May 16, 2024 | 20.39 | -5.82 |
RDDT | May 16, 2024 | 56.38 | 0.00 | |
Redfin | RDFN | May 16, 2024 | 7.65 | -2.67 |
RedHill Biopharma ADR | RDHL | May 16, 2024 | 0.48 | +4.93 |
Redwire | RDW | May 16, 2024 | 4.87 | -2.21 |
Redwood Trust | RWT | May 16, 2024 | 6.63 | +0.15 |
Redwood Trust | RWT-A | May 16, 2024 | 25.03 | +0.24 |
Redwoods Acquisition | RWOD | May 16, 2024 | 6.01 | -0.33 |
Regal Rexnord | RRX | May 16, 2024 | 160.20 | -4.11 |
Regency Centers | REG | May 16, 2024 | 60.12 | -0.71 |
Regency Centers A Pref | REGCP | May 16, 2024 | 23.00 | -0.43 |
Regency Centers B Pref | REGCO | May 16, 2024 | 22.00 | -0.45 |
Regeneron Pharmaceuticals | REGN | May 16, 2024 | 967.98 | -1.05 |
REGENXBIO | RGNX | May 16, 2024 | 16.01 | -1.36 |
Regional Health Properties | RHE | May 16, 2024 | 2.68 | -4.63 |
Regional Health Properties A Pref | RHE-A | May 16, 2024 | 0.64 | 0.00 |
Regional Management | RM | May 16, 2024 | 29.80 | +0.78 |
Regions Financial | RF | May 16, 2024 | 20.10 | -0.79 |
Regions Financial B Pref | RF-B | May 16, 2024 | 25.12 | 0.00 |
Regions Financial C Pref | RF-C | May 16, 2024 | 22.86 | +0.88 |
Regions Financial E Pref | RF-E | May 16, 2024 | 17.95 | +0.22 |
Regis | RGS | May 16, 2024 | 6.25 | -3.55 |
Regulus Therapeutics | RGLS | May 16, 2024 | 2.00 | -0.99 |
Reinsurance Group of America | RGA | May 16, 2024 | 210.23 | +0.75 |
REIT Index ETF Vanguard | VNQ | May 16, 2024 | 84.90 | -0.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.